Improving Health Through Innovative Solutions
Simulations Plus (simulations-plus.com) earns a Brand Analyzer score of 83 out of 100, placing it in the Strong Brand tier among Healthcare brands, SaaS brands, Technology brands. Among 2305 Healthcare brands analyzed, Simulations Plus ranks in the 98th percentile (category average 68, leader 95). The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark. Dimension scores: Name Quality 75/100, Digital Presence 100/100, Visual Identity 93/100, Messaging Clarity 95/100, Trust Foundation 94/100, AI Discoverability 89/100, Brand Authority 48/100.
Simulations Plus is a biosimulation software and consulting company founded in 1996 and headquartered in Lancaster. It provides tools and services that combine AI/machine learning, PBPK/pharmacokinetics, quantitative systems pharmacology, and pharmacometrics to support pharmaceutical and biotech professionals throughout drug discovery, development, and commercialization. The company positions itself as a long-standing leader in model-informed drug development, serving scientists and researchers across the drug development lifecycle.
| Brand Name | Simulations Plus |
|---|---|
| Domain | simulations-plus.com |
| Industry | Healthcare, SaaS |
| Founded | 1996 |
| Headquarters | Lancaster |
| Main Competitors | Certara (87/100), Genedata, Applied BioMath, Metrum Research Group (74/100), Insilico Biotechnology |
Moz Domain Authority 51/100 vs category average 29 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #870,060 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
Simulations Plus has a dedicated Wikipedia entity - a top-weighted signal AI models rely on to identify and describe the brand.
The homepage meta description reads "We offer biosimulation software and solutions which bridge AI/machine learning, PBPK/pharmacokinetics, quantitative systems pharmacology, pharmacometrics" (Meta description: 15 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Social footprint: verified profiles on X (Twitter), LinkedIn, Instagram, YouTube, GitHub; no detected presence on Facebook - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Simulations Plus scores 66/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Simulations Plus has a moderate AI-visibility profile at 66/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (70/100) and its weakest is trust (58/100). It benefits from a recognised Wikipedia company entity, a Wikidata knowledge-graph entry and a global traffic rank of #870,060 (Tranco). The main gaps holding it back: no llms.txt to steer AI to its best pages.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Simulations Plus's main competitors include Certara (87/100), Genedata, Applied BioMath, Metrum Research Group (74/100), Insilico Biotechnology. These companies compete in the Healthcare space for similar customers, offering comparable products or services.
Sources: Simulations Plus official site
Simulations Plus and Certara are competitors in Healthcare. Brand Analyzer scores Simulations Plus at 83/100 and Certara at 87/100. They target overlapping audiences; the right choice depends on your specific needs and priorities.
Sources: Simulations Plus official site
Popular alternatives to Simulations Plus include Certara (87/100), Genedata, Applied BioMath, Metrum Research Group (74/100), Insilico Biotechnology. Each is an established option in the Healthcare space; the best fit depends on your specific needs, budget, and required features.
Sources: Simulations Plus official site
Simulations Plus offers biosimulation software and consulting solutions that support pharmacokinetics/PBPK modeling, quantitative systems pharmacology, pharmacometrics, and AI/machine learning applications for drug discovery, development, and commercialization decision-making.
Sources: Simulations Plus official site
Simulations Plus is a company that develops biosimulation software and provides consulting solutions for the pharmaceutical and life sciences industry. Founded in 1996 and headquartered in Lancaster, it focuses on modeling and simulation tools that integrate AI/machine learning, PBPK/pharmacokinetics, quantitative systems pharmacology, and pharmacometrics to support drug discovery, development, and commercialization.
Sources: Simulations Plus official site
Simulations Plus has moderate AI-search visibility, scoring 66/100 on Brand Analyzer's AI visibility composite (visibility 68, trust 58, recommendation 70). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Simulations Plus official site
Simulations Plus was founded in 1996. Simulations Plus operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
Simulations Plus is headquartered in Lancaster. Simulations Plus operates in the Healthcare category.
Sources: Wikidata
Simulations Plus develops and provides biosimulation software along with expert consulting services that help pharmaceutical and biotech scientists model drug behavior, predict pharmacokinetics, and make data-driven decisions throughout the drug development lifecycle, from early discovery through regulatory review and commercialization.
Sources: Simulations Plus official site
Simulations Plus scores 70/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority; a Wikipedia presence helps.
Sources: Simulations Plus official site
Simulations Plus can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Simulations Plus official site
Simulations Plus is used by pharmaceutical and biotech scientists, researchers, and drug development professionals involved in drug discovery, clinical development, and regulatory or commercialization processes.
Sources: Simulations Plus official site
Simulations Plus is known for its biosimulation software combining PBPK/pharmacokinetics, quantitative systems pharmacology, pharmacometrics, and AI/machine learning approaches used in pharmaceutical drug development. It has positioned itself as a long-established provider in this space, having operated since 1996.
Sources: Simulations Plus official site
Ranked closest to Simulations Plus: PulsePoint (83/100), Myriad Genetics (83/100), UnitedHealth Group (83/100), Amgen (82/100).
A step up - brands to learn from: Abbott (91/100), Wolters Kluwer (92/100).
Category leader: Dassault Systèmes (95/100).